The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure
Abstract
Background Tumor necrosis factor alpha (TNF-α) increases in patients with severe congestive heart failure (CHF) and cachexia. Two naturally occurring modulators of TNF-α activity have been identified in human serum. These two soluble proteins are the extracellular domains of the TNF receptors (sTNF-RI and sTNF-RII, respectively). The determination of circulating sTNF-Rs could provide us with some additional information about the activation of this cytokine in CHF. Methods and Results This study was undertaken to examine the concentration of sTNF-Rs and of bioactive and antigenic TNF-α in 37 consecutive patients with various degrees of CHF compared with that of 26 age-matched healthy subjects. Antigenic TNF-α increased (from 14.3±7.08 to 33.5±13.1 pg/mL, P <.001) in preterminal patients with severe CHF (New York Heart Association [NYHA] class IV). In these patients, sTNF-Rs were also increased (sTNF-RI from 1.17±0.43 to 4.43±2.14 ng/mL and sTNF-RII from 2.2±0.44 to 7.55±2.28 ng/mL, P <.001). When measured by cytolytic bioassay, TNF-α was undetectable (<100 pg/mL). Addition of 625 pg/mL recombinant human TNF-α (rhTNF-α), corresponding in the bioassay to 60% of the lethal dose, to the serum of healthy subjects resulted in a significant increase of the expected cytotoxicity (from 625 to 1290±411 pg/mL, P <.001). Addition of the same dose of rhTNF-α to the serum of patients with mild to moderate CHF (NYHA classes II and III) increased the cytotoxicity from 625 to 877±132 pg/mL, P <.001. In 4 patients with severe CHF (class IV), the expected cytotoxicity was completely inhibited, whereas it was reduced from 625 to 263±198 pg/mL, P <.001, in the remaining 8 patients. Ten patients died within 1 month of entry into the study. They had the highest level of sTNF-RII (8.18±1.92 ng/mL). sTNF-RII was a more powerful independent indicator of mortality than TNF-α, sTNF-RI, NYHA class, norepinephrine, and atrial natriuretic peptide. Conclusions Measurement of sTNF-Rs, in addition to antigenic and bioactive TNF-α, is essential for evaluation of the activation of this cytokine in CHF. Both sTNF-Rs increase in preterminal patients with severe CHF and might inhibit the in vitro cytotoxicity of TNF-α. Antigenic TNF-α also increases in severe CHF. The increased levels of sTNF-RII independently correlate with poor short-term prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
The Pathophysiology Of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.411 · Cited by 1,920
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Tartaglia, L. A., & Goeddel, D. V. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90116-o · Cited by 1,035
Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H., & Widmer, M. B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1548 · Cited by 832
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.323 · Cited by 814
Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., & Wallach, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80162-4 · Cited by 440
Purification and physico-chemical characterization of rabbit tumor necrosis factor.
Ruff, M. R., & Gifford, G. E. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1671 · Cited by 385
Anand, I. S., Ferrari, R., Kalra, G. S., Wahi, P. L., Poole-Wilson, P. A., & Harris, P. C. (1989) · Circulation · doi:10.1161/01.cir.80.2.299 · Cited by 375
Self-citationMcMurray, J., Abdullah, I., Dargie, H. J., & Shapiro, D. (1991) · Heart · doi:10.1136/hrt.66.5.356 · Cited by 344
Aukrust, P., Liabakk, N.-B., ller, F., Lien, E., Espevik, T., & Froland, S. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.420 · Cited by 292
Katz, S. D., Rao, R., Berman, J. W., Schwarz, M., Demopoulos, L., Bijou, R., & LeJemtel, T. H. (1994) · Circulation · doi:10.1161/01.cir.90.1.12 · Cited by 217
Aderka, D., Wysenbeek, A., Engelmann, H., Cope, A. P., Brennan, F., Molad, Y., Hornik, V., Levo, Y., Maini, R. N., Feldmann, M., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360812 · Cited by 174
Tumour necrosis factor alpha in severe congestive cardiac failure.
Dutka, D. P., Elborn, J. S., Delamere, F., Shale, D. J., & Morris, G. K. (1993) · Heart · doi:10.1136/hrt.70.2.141 · Cited by 168
Cytokines and the response to infection
van Deuren, M., Dofferhoff, A. S. M., & van der Meer, J. W. M. (1992) · The Journal of Pathology · doi:10.1002/path.1711680403 · Cited by 156
Ceconi, C., Condorelli, E., Quinzanini, M., Rodella, A., Ferrari, R., & HARRIS, P. (1989) · Cardiovascular Research · doi:10.1093/cvr/23.8.674 · Cited by 61
Self-citationZangerle, R., Gallati, H., Sarcletti, M., Weiss, G., Denz, H. A., Wächter, H., & Fuchs, D. (1994) · PubMed · Cited by 59
Syndromes of cardiac cachexia and the cachectic heart: Current perspective
Ansari, A. (1987) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(87)90010-7 · Cited by 37
Stabilisation of functional tumor necrosis factor-alpha by its soluble TNF receptors.
Groote, D. D., Grau, G. E., Dehart, I., et al. (1994) · PubMed · Cited by 37
Morrison, W. L., & Edwards, R. H. T. (1991) · BMJ · doi:10.1136/bmj.302.6772.301 · Cited by 22
Cited by
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Wasting as independent risk factor for mortality in chronic heart failure
Anker, S. D., Ponikowski, P., Varney, S., Chua, T. P., Clark, A. L., Webb-Peploe, K. M., Harrington, D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07015-8 · Cited by 1,399
Aaronson, K. D., Schwartz, J. S., Chen, T.-M., Wong, K.-L., Goin, J. E., & Mancini, D. M. (1997) · Circulation · doi:10.1161/01.cir.95.12.2660 · Cited by 1,188
Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.16.2055 · Cited by 1,012
Kubota, T., McTiernan, C. F., Frye, C. S., Slawson, S. E., Lemster, B. H., Koretsky, A. P., Demetris, A. J., & Feldman, A. M. (1997) · Circulation Research · doi:10.1161/01.res.81.4.627 · Cited by 829
Metadata
- Authors
- Ferrari, R., Bachetti, T., Confortini, R., Opasich, C., Febo, O., Corti, A., Cassani, G., & Visioli, O.
- Venue
- Circulation
- Published
- 1995-09-15
- Volume
- 92
- Issue
- 6
- Pages
- 1479-1486
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2063254774
- Cited by
- 536
- References
- 22
- FWCI
- 17.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.